Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nano-X Imaging (NNOX) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Nano-X Imaging (NNOX) over the last 6 years, with Q3 2025 value amounting to $45.2 million.

  • Nano-X Imaging's Cash & Equivalents fell 1985.03% to $45.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.2 million, marking a year-over-year decrease of 1985.03%. This contributed to the annual value of $56.4 million for FY2024, which is 4632.35% up from last year.
  • Per Nano-X Imaging's latest filing, its Cash & Equivalents stood at $45.2 million for Q3 2025, which was down 1985.03% from $49.9 million recorded in Q2 2025.
  • Over the past 5 years, Nano-X Imaging's Cash & Equivalents peaked at $219.3 million during Q1 2021, and registered a low of $37.6 million during Q1 2023.
  • Over the past 5 years, Nano-X Imaging's median Cash & Equivalents value was $55.0 million (recorded in 2022), while the average stood at $63.7 million.
  • As far as peak fluctuations go, Nano-X Imaging's Cash & Equivalents tumbled by 7489.75% in 2022, and later soared by 6459.8% in 2023.
  • Quarter analysis of 5 years shows Nano-X Imaging's Cash & Equivalents stood at $66.8 million in 2021, then plummeted by 42.4% to $38.5 million in 2022, then skyrocketed by 46.57% to $56.4 million in 2023, then tumbled by 30.28% to $39.3 million in 2024, then grew by 14.97% to $45.2 million in 2025.
  • Its Cash & Equivalents was $45.2 million in Q3 2025, compared to $49.9 million in Q2 2025 and $39.3 million in Q1 2025.